SPARC and urinary bladder cancer: In addition, TCGA data [48] revealed the enrichment of signaling pathways that were inhibited by SPARC in ovarian cancer [7, 23, 24] as phosphatidylinositol-3-OH kinase/AKT/mTOR pathway and the RTK/MAPK pathway suggesting potential inhibitory effect in bladder cancer milieu.